Fundraising FoxVersant Ventures — 2015 Investments
4 investments dated 2015 · listed companies and verified rows first · show all
HealthtechSt Louis, US
Andrea M. Clegg(Executive Officer)Louis Silverman(Executive Officer, Director)
BoardBarbara Lubash(Director)inMichael Mikolajczyk(Director)Timothy B. Petersen(Director)inDavid N. Schopp(Director)
Co-investorsArboretum Ventures
Nexoplex Bio develops immunotherapies designed to target tumors through recognition of HLA-peptide complexes using multi-specific antibodies, aimed at cancers including certain lung, gastric, esophageal, head and neck, and cervical cancers.
BiotechHealthtechSan Carlos, US
Andrew Allen(Executive Officer, Director)inVassiliki Economides(Executive Officer)Matthew Hawryluk(Executive Officer)inWayne(CEO)Rachel(VP of Operations)Shefali Agarwal(Director)
Co-investorsFrazier Life SciencesGV (Google Ventures)Sofinnova VenturesThe Column GroupREDMILE
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.